A designed chimeric virus induced broadly neutralizing antibodies against the macaque equivalent of HIV. The strategy works ...

Study results indicate suboptimal adherence to HIV-specific immunization recommendations among pediatric patients receiving ...

Human immunodeficiency virus, or HIV — the infection that can damage the immune system and lead to the deadly disease AIDS — hasn’t been in the news as much as it was during the beginning of the AIDS ...

New HIV research reveals how broadly neutralizing antibodies may transform treatment despite the virus's rapid mutation and ...

The Food and Drug Administration blocked the publication of studies that tracked the safety of the COVID-19 and shingles ...

Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.

Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, ...

Fauci says anti-vax culture kept the US from reaching 72% vaccination, but highly vaccinated countries still saw record COVID ...

Biktarvy continues to be a strong growth asset for Gilead, while Yeztugo’s launch rides an upward trajectory.

In this era of the HIV epidemic, talking saves lives. It pierces stigma and turns ordinary conversation into something ...

Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings come ...